AF Online - Community Virtual Meet Up 24
Join us for our virtual get together on Thursday Oct. 28th, 10-11am PST.
Angel Forum Members: make sure to register so we can send you a personalized zoom link.
If you are not an Angel Forum member and are an accredited investor, we encourage you to attend as our guest. Please send me an e-mail so we can take care of registration.
We are hosting AF Virtual Meet Ups to stay connected and discuss and find out how we can support and further build the early stage ecosystem in these volatile times. In addition, we look forward to welcoming 2-3 promising companies who will present for 10 minutes each.
Join us once or participate monthly! Even if you are just showing up to listen as part of the call your presence is welcomed and appreciated.
Register below and we will send you the details by October 27th, including information on the companies presenting and zoom link.
Hope you can join us!
Geenees is a social gifting platform for families in need and changing the way people give. Geenees leverages affiliate partnerships with retailers and service providers allowing 100% of the donation to go to the families. Nonprofits choose families to create wish lists. Donors purchase items on the wish list through the online platform which are delivered directly the families.
Geenees allows families to receive essential products, groceries and dental and educational services anonymously and nonprofits to find new types of donors and easily facilitate contact less donations.
|VoxCell is a biotechnology start-up focused on providing an extraordinary line of solutions for the drug development industry and the field of Oncology research by creating 3D vascularized cancer tissue models. They offer three core products: Bioinks, Tissue Models, and an ultra-high resolution 3D Bioprinter for in vitro drug testing. VoxCell’s mission is to impact the world by reducing the time and increasing the confidence of getting new drug therapies to market by allowing researchers and pharmaceutical companies to test sooner on Truly Biomimetic tissues.|
|HTuO Biosciences is a computational biotechnology company, founded in September 2020, that is based on a novel molecular physics model designed to significantly improve the accuracy of molecular scale predictions. Our goal is to disrupt the drug innovation field by changing the way drugs are designed and optimized, with the goal of developing drugs that are more likely to demonstrate efficaciousness in clinical trials, and are less expensive to get to the clinic. HTuO has demonstrated a prototype of its platform that illustrates one of the key features of the technology and will focus on applying the tools in-house to develop a rich pipeline of pharmaceutical products for hard to target or “undruggable" diseases.|